An Israeli company has developed a novel diagnostic tool for diabetic patients and is looking for commercial agency or distribution agreements.
A leading Israeli company, specializing in the development, manufacturing and marketing of high quality medical diagnostic kits and systems has a novel test developed to determine the Haptoglobin type, a predictive marker for high risk of developing cardiovascular complications, in human serum. The company is looking for a commercial agency agreement and distribution services agreement, to expand the sales of the test.